|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-30
|
$1,889,710
|
$94,486
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
Z01 CP010183-00580
|
$179,292
|
$8,965
|
Anderson, William
|
DCEG (NCI)
|
|
UWCCC National Cooperative Drug Discovery Group for Can*
|
3U19CA113297-04S1
|
$25,000
|
$6,250
|
SHEN, BEN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UWCCC National Cooperative Drug Discovery Group for Can*
|
5U19CA113297-04
|
$1,044,616
|
$261,154
|
SHEN, BEN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
$2,398
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
$191,819
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$87,938
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USC Center for Transdisciplinary Research on Energetics*
|
3U54CA116848-04S1
|
$62,100
|
$31,050
|
GORAN, MICHAEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Center for Transdisciplinary Research on Energetics*
|
5U54CA116848-04
|
$2,254,533
|
$1,127,267
|
GORAN, MICHAEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S1
|
$80,987
|
$17,817
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-24
|
$1,553,887
|
$341,855
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-21S1
|
$61,058
|
$2,442
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-21
|
$5,994,681
|
$239,787
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
1P30CA134274-01
|
$1,463,613
|
$14,636
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Underutilization of Surgical Resection in Patients with Pancreatic Cancer
|
1K07CA130983-01A1
|
$126,591
|
$126,591
|
RIALL, TAYLOR
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Tumor Suppressor Function of Smad4 by Ubiquitin
|
5R01CA108454-05
|
$224,756
|
$112,378
|
FENG, XIN-HUA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Tumor Radiosensitization by Prenyltransferase Inhibitors
|
5R01CA073820-10
|
$87,556
|
$87,556
|
BERNHARD, ERIC
|
UNIVERSITY OF OXFORD
|
|
Tumor maintenance and development in mouse models
|
5U01CA105492-05
|
$464,773
|
$158,023
|
VARMUS, HAROLD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Tumor Hypoxia: Molecular Studies & Clinical Exploitation
|
5P01CA067166-12
|
$1,605,434
|
$1,091,695
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers
|
5U01CA128454-02
|
$411,357
|
$411,357
|
PIERCE, J
|
UNIVERSITY OF GEORGIA (UGA)
|
|
Translational Research in Cancer
|
2P30CA056036-09
|
$3,116,058
|
$62,321
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-09S1
|
$63,390
|
$1,268
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Transforming growth factor beta signaling pathways
|
5R01CA055536-17
|
$308,158
|
$77,040
|
HOWE, PHILIP
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Transcriptional control in the genesis of pancreatic intraepithelial neoplasia
|
5R21CA127822-02
|
$179,400
|
$179,400
|
Ayer, Donald
|
UNIVERSITY OF UTAH
|
|
Traget-Driven Identification of Diagnostic Patterns in Pancreatic Adenocarcinoma
|
5R03CA130104-02
|
$77,250
|
$77,250
|
SILLETTI, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Tissue and Tumor Specific Glycosylation of Proteins
|
5F32CA128338-02
|
$49,646
|
$24,823
|
West, Matthew
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial
|
5R44CA075923-08
|
$973,839
|
$973,839
|
KIRKPATRICK, LYNN
|
PROLX PHARMACEUTICALS CORPORATION
|
|
Therapeutic Targeting of Hypoxic and Oxidative Stress
|
5P01CA017094-29
|
$1,244,592
|
$622,296
|
DORR, ROBERT
|
UNIVERSITY OF ARIZONA
|
|
Therapeutic Application of Novel Stat3 Inhibitors in Breast and Pancreatic Cancer
|
1R01CA128865-01A1
|
$188,029
|
$94,015
|
TURKSON, JAMES
|
UNIVERSITY OF CENTRAL FLORIDA
|
|
The tumor-suppressive role of ALK4/ACVR1B in pancreatic tumorigenesis
|
1R21CA127701-01A2
|
$217,350
|
$217,350
|
SU, GLORIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
Z01 SC 010373
|
$631,181
|
$63,118
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The role of RalA in pancreatic tumorigenesis
|
1K08CA127518-01A2
|
$130,329
|
$130,329
|
KENDALL, STEPHAN
|
DUKE UNIVERSITY
|
|
The role of n-3 polyunsaturated fatty acids in pancreatic cancer
|
5R01CA122042-02
|
$292,600
|
$292,600
|
Eibl, Guido
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
The Role of MUC1 in the Pathogenesis of Pancreatic Cancer
|
1R21CA131663-01A1
|
$203,850
|
$203,850
|
SALUJA, ASHOK
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
The role of FoxM1 in pancreatic cancer
|
1R21CA134615-01
|
$141,300
|
$141,300
|
GARTEL, ANDREI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
|
1K08CA129204-01A1
|
$135,270
|
$67,635
|
ZEISBERG, ELISABETH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The Role of CXCR2 in Pancreatic Cancer
|
5R21CA124609-02
|
$154,000
|
$154,000
|
Hines, Oscar
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S1
|
$91,948
|
$3,678
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S2
|
$49,383
|
$1,975
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S3
|
$83,152
|
$3,326
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-15
|
$5,084,061
|
$203,362
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The RaLGTPase Regulatory Network
|
5R01CA129451-02
|
$238,640
|
$119,320
|
White, Michael
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-33S1
|
$89,606
|
$2,688
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-33
|
$3,753,703
|
$112,611
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Molecular Analysis of Tumor Viruses
|
5T32CA009043-34
|
$624,449
|
$62,445
|
BISHOP, J
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
The Inhibition of HSP70 Induces Apoptosis in Pancreatic Cancer Cells
|
5R01CA124723-02
|
$284,050
|
$284,050
|
SALUJA, ASHOK
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
The Impact of Cultural Differences on Health Literacy & Chronic Disease Outcomes
|
5R01CA128455-03
|
$208,381
|
$68,766
|
SHAW, SUSAN
|
UNIVERSITY OF ARIZONA
|
|
The Hedgehog Pathway in Injury-Associated Pancreatic Carcinogenesis
|
5F32CA121733-02
|
$51,278
|
$51,278
|
GUO, NINI
|
JOHNS HOPKINS UNIVERSITY
|
|
The Early Detection Research Network: Biomarker Referen*
|
5U24CA086366-09
|
$473,491
|
$47,349
|
CHIA, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
The Cholecystokinin-C (CCK-C) Receptor for Early Detection of Pancreatic Cancer
|
5R01CA117926-02
|
$286,900
|
$286,900
|
SMITH, JILL
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
Total relevant funding to Pancreas for this search: $87,277,150
|